Literature DB >> 22527681

Recent advances in the genetics of cerebellar ataxias.

Anna Sailer1, Henry Houlden.   

Abstract

The hereditary cerebellar ataxias are a clinically and genetically heterogeneous group of disorders that primarily affect the cerebellum; often there are additional features such as neuropathy, cognitive decline, or maculopathy that help define the clinical subtype of ataxia. They are commonly classified according to their mode of inheritance into autosomal dominant, autosomal recessive, X-linked, and mitochondrial forms. Great advances have been made in understanding the genetics of cerebellar ataxias in the last 15 years. At least 36 different forms of ADCA are known, 20 autosomal-recessive, two X-linked, and several forms of ataxia associated with mitochondrial defects are known to date. However, in about 40 % of suspected genetically determined ataxia cases, the underlying genetic defect remains undetermined. Although the majority of disease genes have been found in the last two decades, over the last 2 years the genetics has undergone a methodological revolution. New DNA sequencing technologies are enabling us to investigate the whole or large targeted proportions of the genome in a rapid, affordable, and comprehensive way. Exome and targeted sequencing has recently identified four new genes causing ataxia: TGM6, ANO10, SYT14, and rundataxin. This approach is likely to continue to discover new ataxia genes and make screening of existing genes more effective. Translating the genetic findings into isolated and overlapping disease pathways will help stratify patient groups and identify therapeutic targets for ataxia that have so far remained undiscovered.

Entities:  

Mesh:

Year:  2012        PMID: 22527681     DOI: 10.1007/s11910-012-0267-6

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  78 in total

1.  Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12.

Authors:  S E Holmes; E E O'Hearn; M G McInnis; D A Gorelick-Feldman; J J Kleiderlein; C Callahan; N G Kwak; R G Ingersoll-Ashworth; M Sherr; A J Sumner; A H Sharp; U Ananth; W K Seltzer; M A Boss; A M Vieria-Saecker; J T Epplen; O Riess; C A Ross; R L Margolis
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

2.  Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes.

Authors:  Michael F Waters; Natali A Minassian; Giovanni Stevanin; Karla P Figueroa; John P A Bannister; Dagmar Nolte; Allan F Mock; Virgilio Gerald H Evidente; Dominic B Fee; Ulrich Müller; Alexandra Dürr; Alexis Brice; Diane M Papazian; Stefan M Pulst
Journal:  Nat Genet       Date:  2006-02-26       Impact factor: 38.330

3.  Splice isoform-specific suppression of the Cav2.1 variant underlying spinocerebellar ataxia type 6.

Authors:  Wei-Ling Tsou; Bing-Wen Soong; Henry L Paulson; Edgardo Rodríguez-Lebrón
Journal:  Neurobiol Dis       Date:  2011-04-29       Impact factor: 5.996

4.  Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA).

Authors:  Sarah J Lagedrost; Martin St John Sutton; Meryl S Cohen; Gary M Satou; Beth D Kaufman; Susan L Perlman; Christian Rummey; Thomas Meier; David R Lynch
Journal:  Am Heart J       Date:  2011-01-31       Impact factor: 4.749

5.  Spinocerebellar ataxia type 11 (SCA11) is an uncommon cause of dominant ataxia among French and German kindreds.

Authors:  Peter Bauer; Giovanni Stevanin; Christian Beetz; Matthis Synofzik; Tanja Schmitz-Hübsch; Ullrich Wüllner; Eric Berthier; Elisabeth Ollagnon-Roman; Olaf Riess; Sylvie Forlani; Emeline Mundwiller; Alexandra Durr; Ludger Schöls; Alexis Brice
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-28       Impact factor: 10.154

Review 6.  Clinical experience with high-dose idebenone in Friedreich ataxia.

Authors:  Jörg B Schulz; Nicholas A Di Prospero; Kenneth Fischbeck
Journal:  J Neurol       Date:  2009-03       Impact factor: 4.849

7.  Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein.

Authors:  K Ouahchi; M Arita; H Kayden; F Hentati; M Ben Hamida; R Sokol; H Arai; K Inoue; J L Mandel; M Koenig
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

8.  Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome.

Authors:  Peter K Todd; Seok Yoon Oh; Amy Krans; Udai B Pandey; Nicholas A Di Prospero; Kyung-Tai Min; J Paul Taylor; Henry L Paulson
Journal:  PLoS Genet       Date:  2010-12-09       Impact factor: 5.917

9.  HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model.

Authors:  Myriam Rai; Elisabetta Soragni; Kai Jenssen; Ryan Burnett; David Herman; Giovanni Coppola; Daniel H Geschwind; Joel M Gottesfeld; Massimo Pandolfo
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240

10.  Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans.

Authors:  Joyce van de Leemput; Jayanth Chandran; Melanie A Knight; Lynne A Holtzclaw; Sonja Scholz; Mark R Cookson; Henry Houlden; Katrina Gwinn-Hardy; Hon-Chung Fung; Xian Lin; Dena Hernandez; Javier Simon-Sanchez; Nick W Wood; Paola Giunti; Ian Rafferty; John Hardy; Elsdon Storey; R J McKinlay Gardner; Susan M Forrest; Elizabeth M C Fisher; James T Russell; Huaibin Cai; Andrew B Singleton
Journal:  PLoS Genet       Date:  2007-05-16       Impact factor: 5.917

View more
  32 in total

1.  Homozygous splice mutation in CWF19L1 in a Turkish family with recessive ataxia syndrome.

Authors:  Randi Burns; Karen Majczenko; Jishu Xu; Weiping Peng; Zuhal Yapici; James J Dowling; Jun Z Li; Margit Burmeister
Journal:  Neurology       Date:  2014-10-31       Impact factor: 9.910

2.  Genetics of ataxias: hereditary forms.

Authors:  N Tirada; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-12-26       Impact factor: 3.825

3.  A novel frameshift mutation in FGF14 causes an autosomal dominant episodic ataxia.

Authors:  Karine Choquet; Roberta La Piana; Bernard Brais
Journal:  Neurogenetics       Date:  2015-01-08       Impact factor: 2.660

4.  Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination.

Authors:  David H Margolin; Maria Kousi; Yee-Ming Chan; Elaine T Lim; Jeremy D Schmahmann; Marios Hadjivassiliou; Janet E Hall; Ibrahim Adam; Andrew Dwyer; Lacey Plummer; Stephanie V Aldrin; Julia O'Rourke; Andrew Kirby; Kasper Lage; Aubrey Milunsky; Jeff M Milunsky; Jennifer Chan; E Tessa Hedley-Whyte; Mark J Daly; Nicholas Katsanis; Stephanie B Seminara
Journal:  N Engl J Med       Date:  2013-05-08       Impact factor: 91.245

5.  Ataxia and hypogonadism caused by the loss of ubiquitin ligase activity of the U box protein CHIP.

Authors:  Chang-He Shi; Jonathan C Schisler; Carrie E Rubel; Song Tan; Bo Song; Holly McDonough; Lei Xu; Andrea L Portbury; Cheng-Yuan Mao; Cadence True; Rui-Hao Wang; Qing-Zhi Wang; Shi-Lei Sun; Stephanie B Seminara; Cam Patterson; Yu-Ming Xu
Journal:  Hum Mol Genet       Date:  2013-10-09       Impact factor: 6.150

6.  Autosomal dominant SCA5 and autosomal recessive infantile SCA are allelic conditions resulting from SPTBN2 mutations.

Authors:  Solaf M Elsayed; Raoul Heller; Michaela Thoenes; Maha S Zaki; Daniel Swan; Ezzat Elsobky; Christine Zühlke; Inga Ebermann; Gudrun Nürnberg; Peter Nürnberg; Hanno J Bolz
Journal:  Eur J Hum Genet       Date:  2013-07-10       Impact factor: 4.246

7.  Paradigm for disease deconvolution in rare neurodegenerative disorders in Indian population: insights from studies in cerebellar ataxias.

Authors:  Renu Kumari; Deepak Kumar; Samir K Brahmachari; Achal K Srivastava; Mohammed Faruq; Mitali Mukerji
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

8.  SYNE1 related cerebellar ataxia presents with variable phenotypes in a consanguineous family from Turkey.

Authors:  E Yucesan; Sibel A Ugur Iseri; B Bilgic; Z Gormez; B Bakir Gungor; A Sarac; O Ozdemir; M Sagiroglu; H Gurvit; H Hanagasi; U Ozbek
Journal:  Neurol Sci       Date:  2017-07-07       Impact factor: 3.307

9.  The L450F [Corrected] mutation in KCND3 brings spinocerebellar ataxia and Brugada syndrome closer together.

Authors:  Anna Duarri; Esther Nibbeling; Michiel R Fokkens; Michel Meijer; Erik Boddeke; Emmeline Lagrange; Giovanni Stevanin; Alexis Brice; Alexandra Durr; Dineke S Verbeek
Journal:  Neurogenetics       Date:  2013-08-21       Impact factor: 2.660

Review 10.  A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases.

Authors:  Jane S Paulsen; Martha Nance; Ji-In Kim; Noelle E Carlozzi; Peter K Panegyres; Cheryl Erwin; Anita Goh; Elizabeth McCusker; Janet K Williams
Journal:  Prog Neurobiol       Date:  2013-09-11       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.